This potentially argues in favor of the infiltration of inflammatory monocytes into the CNS of MS patients, since IL-1β promotes their differentiation into antigen-presenting cells to activate CD4 reactive cells (Paré et al., 2018). This evidence concerns the gene IL1B and myeloid sarcoma.